RHY 4.11% 7.0¢ rhythm biosciences limited

News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods, page-41

  1. 1,538 Posts.
    lightbulb Created with Sketch. 148
    surely colostat is a cheaper alternative to fobt and the reason why rhy aim to make it an affordable test. Colostat is more accurate as it tests for the cancer, likely will be less costly, and uptake will be higher given it can be done with other routine blood tests
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.